{"name":"Lars Olaf Cardell","slug":"lars-olaf-cardell","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","status":"active","statusNote":"","leadDrug":"","leadIndication":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Respiratory","slug":"respiratory","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"ALK Alutard 5-grasses","genericName":"ALK Alutard 5-grasses","slug":"alk-alutard-5-grasses","indication":"Allergic rhinitis","status":"phase_2"}]},{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"immunology","drugs":[{"name":"ALK Alutard 5-grasses and birch","genericName":"ALK Alutard 5-grasses and birch","slug":"alk-alutard-5-grasses-and-birch","indication":"Other","status":"phase_1"}]}],"pipeline":[{"name":"ALK Alutard 5-grasses","genericName":"ALK Alutard 5-grasses","slug":"alk-alutard-5-grasses","phase":"phase_2","mechanism":"ALK Alutard 5-grasses is an immunotherapy that targets the CD25 antigen.","indications":["Allergic rhinitis","Asthma"],"catalyst":""},{"name":"ALK Alutard 5-grasses and birch","genericName":"ALK Alutard 5-grasses and birch","slug":"alk-alutard-5-grasses-and-birch","phase":"phase_1","mechanism":"Allergen immunotherapy that induces immune tolerance by gradually exposing the immune system to increasing doses of grass and birch pollen allergens.","indications":[],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiX0FVX3lxTE45YjJqTzNTWVVRUmVmdDQwcmNWcUpwX3B2d09xd19zNFZkWHNJM3NEaHVfT0wzVlREU2xlR3hQMF96VjJMUVNPUm5qNTRqNFVCSEpIa2dvNkt0SDlDd0ZV?oc=5","date":"2025-11-10","type":"pipeline","source":"Nature","summary":"Nasal allergen challenge with dissolved birch tree pollen tablets - Scientific Reports - Nature","headline":"Nasal allergen challenge with dissolved birch tree pollen tablets - Scientific Reports","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiX0FVX3lxTE9VYS1aZVdSLWw5aTg4NVpVeElUN2ota25GRDVCWmZQdk5TOHRkaklsd281cUlWOXZFS3ZYblh2NUM2Umx4M1RjQy1HbmlENkFDOS1oXzhzUTltYlJZTzdr?oc=5","date":"2024-01-18","type":"pipeline","source":"Nature","summary":"Modelling the impact of sublingual immunotherapy versus subcutaneous immunotherapy on patient travel time and CO - Nature","headline":"Modelling the impact of sublingual immunotherapy versus subcutaneous immunotherapy on patient travel time and CO","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiWEFVX3lxTE1GYzZ5R3h3T1FWc3ZGb19NclN5a3RJa3JubWR3eTRSWXMwOVFCSUFUSWxIeXBqS2pkWWlLOU56V0pFWnVLRXU0VGVFYmFZUkphYmNMcVBrRlU?oc=5","date":"2016-02-04","type":"trial","source":"Nature","summary":"TOTALL: high cost of allergic rhinitis—a national Swedish population-based questionnaire study - Nature","headline":"TOTALL: high cost of allergic rhinitis—a national Swedish population-based questionnaire study","sentiment":"neutral"}],"patents":[],"drugCount":2,"phaseCounts":{"phase_2":1,"phase_1":1},"enrichmentLevel":2,"visitCount":3,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}